Investment
Features
FeesSafety
Academy
More
Pluang+

HCA Healthcare remains a Buy with strong revenue growth and positive healthcare demand trends.

Analyst Insights
13 Oct 2026
Seeking Alpha
View Source
Bullish
HCA Healthcare remains a Buy with strong revenue growth and positive healthcare demand trends.

HCA Healthcare is rated as a Buy due to its strong revenue growth and favorable demographic trends driving healthcare demand. Despite some margin pressure from changes in payer mix, the company saw a 6% increase in revenue per equivalent admission and improved occupancy year-over-year. Management expects revenue to grow to $77–$79.5 billion by 2026, though net income and EBITDA forecasts have been slightly lowered. Investors should watch upcoming Q3 results for any significant changes in outlook.

HCA Healthcare is the subject of this update, with Pluang market data as context. As of Oct 13, 2026 22:41 WIB, out of 128 priced US health-sector stocks tradable on Pluang, 30 rose and 98 fell. Notable movers include INO at USD 1.02 with a 1-day change of -7.69%, SMMT at USD 15.85 down 7.47%, and HRTX at USD 0.39 down 5.82%.

More News

Ollie's Bargain Outlet gains investor confidence with $105 price target and $500M share buyback boost

Ollie's Bargain Outlet gains investor confidence with $105 price target and $500M share buyback boost

Gordon Haskett Capital Corporation set a $105 price target for Ollie's Bargain Outlet, suggesting an 18.1% upside from its current price around $89. The company’s board approved an additional $500 million share repurchase authorization, increasing to...

Market News
Bullish
51 minutes ago
FRUIT launches PAVE to integrate human judgment into AI decision-making systems.

FRUIT launches PAVE to integrate human judgment into AI decision-making systems.

FRUIT Holdings, Inc. introduced PAVE, a new protocol designed to allow AI systems to call on human judgment and authority when needed. This approach ensures that human input retains its value, authority, and attribution within AI workflows, addressin...

Others
Bullish
53 minutes ago
AngioDynamics Q1 revenue rises 6.9%, but shares drop 21% despite positive results and CEO change.

AngioDynamics Q1 revenue rises 6.9%, but shares drop 21% despite positive results and CEO change.

AngioDynamics reported a 6.9% revenue increase to $80.9 million and a narrowed adjusted loss of 4 cents per share for Q1 fiscal 2027, with strong Med Tech sales growing 13.2%. Despite beating earnings expectations and improved gross margin, the stock...

Company Fundamentals
Bearish
1 hour ago
Domino's Q3 earnings beat estimates despite slow sales and declining cash flow

Domino's Q3 earnings beat estimates despite slow sales and declining cash flow

Domino's Pizza reported Q3 2026 earnings per share of $4.60, beating analyst expectations of $4.37, while revenue grew modestly by 3.4% to $1.19 billion. Same-store sales growth was minimal at 0.3% in the U.S. and 0.2% internationally, reflecting com...

Company Fundamentals
Neutral
2 hours ago
Citigroup Q3 2026 earnings beat estimates with 40% profit surge led by strong trading.

Citigroup Q3 2026 earnings beat estimates with 40% profit surge led by strong trading.

Citigroup reported Q3 2026 earnings that exceeded analyst expectations, with EPS of $2.85 beating the $2.65 estimate and revenue of $23.8 billion slightly above forecasts. The bank's profit rose 40%, driven by exceptional fixed-income trading, invest...

Company Fundamentals
Bullish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App